SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Ligand (LGND) Breakout! -- Ignore unavailable to you. Want to Upgrade?


To: Mudcat who wrote (17152)3/11/1998 8:34:00 AM
From: Henry Niman  Respond to of 32384
 
LGND is running a Phase II/III trial with Targretin (see home.att.net ). Hundreds of researchers are using Targretin and Panretin in their studies. To my knowledge, the Turkey data was generated independently, although LGND may have provided the drug.